ライフサイエンスコーパス: age-matched

1 llergic and egg-sensitized and egg-tolerant, age-matched 12-month infants with longitudinal follow-up

2 tnatal day 7 but were significantly lower in age-matched adult females than in adult males.

3 yzed their cases in comparison with sex- and age-matched anaphylaxis cases triggered by other elicito

4 ildren with moderate-to-severe diarrhoea and age-matched and community-matched controls were included

5 een participants with early-stage ALS and 18 age-matched and sex ratio-matched controls underwent ult

6 Age-matched and sex-frequency-matched community controls

7 3, with relevant respiratory diagnoses, with age-matched and sex-matched control groups.

8 cortex (DLPFC) derived from 17 patients and age-matched and sex-matched controls.

9 in a subgroup of 38 patients with FMD and 38 age-matched and sex-matched healthy controls.

10 Compared with the UK age-matched and sex-matched population, the 1-year stand

11 our population with published UK population age-matched and sex-matched rates.

12 Age-matched and sex-matched WT (n = 8) and Cld-1 Tg (n =

13 s (ASDs) imitate observed behavior less than age-matched and typically developing peers, resulting in

14 erase chain reaction (qPCR) in 29 weight and aged matched anovulatory women with PCOS and 30 women wi

15 nd that transplants of fecal microbiota from age-matched APPPS1-21 male mice into ABX-treated APPPS1-

16 -8, and 18-20 month-old male AbetaPP/PS1 and age-matched C57BL/6J control mice.

17 s adjacent to tumors and normal tissues from age-matched cancer-free women from the GEO BRCA data and

18 ch parents of 99 unilateral and 56 bilateral age-matched case-control pairs were interviewed by telep

19 This 1:1 age-matched case-control study identified 735 female bre

20 this hospital-based surveillance and nested age-matched case-control study, we did laboratory invest

21 samples from genotyped patients with CHD and age-matched CHD-free controls was determined using quant

22 were significantly upregulated compared with age-matched CHD-free controls, suggesting that this powe

23 n after initiation of islet autoimmunity and age-matched children who did not develop islet autoantib

24 showed superior task performance compared to age-matched children, but had qualitatively distinct coo

25 As a positive internal control, we studied age-matched cigarette smokers (n=15) who smoked 1 cigare

26 ing sequences: 70 patients with bvFTD and 78 age-matched cognitively healthy controls.

27 than Alzheimer's disease, though higher than age-matched, cognitively normal controls.

28 lzheimer's disease patient versus a group of age-matched, cognitively normal subjects across two inde

29 CTS, and they were compared with a sex- and age-matched cohort (ratio 1:1) from the general populati

30 vere or uncomplicated malaria and in healthy age-matched community controls.

31 een RV1-vaccinated infants with RVGE and 1:1 age-matched community controls.

32 986-2016 with LNB (n=2,067) and a gender and age matched comparison cohort from the general populatio

33 6 with LNB (n = 2067), created a gender- and age-matched comparison cohort from the general populatio

34 dhood and adolescent cancer survivors and an age-matched comparison group.

35 med untargeted global metabolic profiling of age-matched control and FXTAS mice cerebella at 16-20 we

36 tor cell (OPC) maturation, whereas NPCs from age-matched control cell lines did so efficiently.

37 tterns of CTBs from PAS cases to gestational age-matched control cells that invaded to the normal dep

38 oroid of the aged CFH-H/H mice compared with age-matched control CFH-Y/0 fed a HFC diet.

39 and 17 with active rejection, along with 32 age-matched control eyes) were imaged using high-definit

40 Outcomes were compared with an age-matched control group of 18 successful primary DMEK

41 P-bicarbonate from HP-[1-(13)C]pyruvate than age-matched control livers.

42 e developed tumors, as compared with 100% of age-matched control mice.

43 pulation at the Duke Eye Center, and healthy age-matched control participants were recruited from fam

44 st cancer an average of 2 years later and in age-matched control patients.

45 iabetes (2 weeks, in vivo hyperglycemia) and age-matched control pigs for vasoreactivity and molecula

46 of increase in AD plasma in comparison with age-matched control plasma.

47 C-biomarkers were compared with an age-matched control population and with 2-dimensional pr

48 H activity in dermal fibroblasts compared to age-matched control samples.

49 n SCORAD score, 55 and 65, respectively) and age-matched control subjects (15 children and 27 adults)

50 w a reduction in loss aversion compared with age-matched control subjects (females, 11; males, 9).

51 nts with moderate-to-severe AD (n = 246) and age-matched control subjects (n = 71) using immunohistoc

52 h diabetes without retinopathy compared with age-matched control subjects (P < 0.001).

53 reated with methotrexate and eight untreated age-matched control subjects by using Wilcoxon rank-sum

54 lass deficiency with IgA deficiency, and 223 age-matched control subjects were studied by using flow

55 activity in 12 svPPA patients and 12 healthy age-matched control subjects while reading irregular wor

56 e = 7.88 years; 27 females) as compared with age-matched control subjects without diabetes (n = 26; m

57 brain scans from 49 HD gene carriers and 49 age-matched control subjects, we implemented a novel dyn

58 avoid punishment when compared with healthy age-matched control subjects.

59 detectable diabetic retinopathy (DR) and 57 age-matched control subjects.

60 e and exudative AMD in the fellow eye, and 8 age-matched control subjects.

61 compared with those obtained from 10 healthy age-matched control subjects.

62 ld or older (n = 43) patients with AD versus age-matched control subjects.

63 electrophysiological changes, compared with age-matched control subjects.

64 urns these morphological alterations back to age-matched control values.

65 pressure/volume overload-induced HF (versus age-matched control).

66 Compared with age-matched control, four specific miRNAs (miR-132-3p, m

67 patients and periodontally healthy, sex- and age-matched controls (50 per group) were included.

68 iffer between ROS or ES and their respective age-matched controls (ACC; ANOVA main effect of diagnosi

69 st-mortem brain tissues and compared them to age-matched controls (CNTs).

70 rkers in plasma, compared with neurotypical, age-matched controls (n = 16, mean age = 29.6 y).

71 (PEs) at age 18 (n = 64) were compared with age-matched controls (n = 67).

72 ely to have community type O microbiota than age-matched controls (OR 2.79 [95% CI 1.25-6.68]; p=0.01

73 tinnitus subjects, but not in 26 hearing and age-matched controls (p < 0.001, receiver operator chara

74 trometry in 115 CRC patients and 76 sex- and age-matched controls and analyzed the results with respe

75 me sequencing data of 4549 AD cases and 3332 age-matched controls and discovered that rare protein al

76 Patients were eligible for inclusion as age-matched controls if they were treated for lymphoma,

77 transcriptional changes of sarcopenia versus age-matched controls in muscle biopsies from 119 older m

78 The resulting phenotype was compared with age-matched controls maintained on ND.

79 We also sampled 194 age-matched controls twice 2-3 weeks apart.

80 ence of community type O microbiota than did age-matched controls under a logistic regression model w

81 's Disease (3xTg-AD) mice and wild type (WT) age-matched controls using co-registered angle-resolved

82 and presymptomatic subjects were compared to age-matched controls using mixed-effects models, control

83 nts with early-stage to mid-stage PD, and 37 age-matched controls using the Montreal Cognitive Assess

84 In addition, age-matched controls were enrolled for a subset of cases

85 ator group of healthy HIV-uninfected (HIV-), age-matched controls were enrolled in CTAAC.

86 action to labile plant food allergens and on age-matched controls with a history of oral allergy synd

87 Age-matched controls with high (>=1:20) and negative tit

88 between people with Alzheimer's Disease and age-matched controls, but also between individuals with

89 he plasma of DMD patients in comparison with age-matched controls, is reduced by GC treatment.

90 nd break (DSB) marker gammaH2AX, compared to age-matched controls, suggesting a role of the Q331K mut

91 beta-amyloid deposition was lower in MS than age-matched controls, suggesting that some aspect of MS

92 tral lipid content was unchanged relative to age-matched controls, the levels of whole SN triglycerid

93 s Permeable contact lenses (RGP CL's) and 20 age-matched controls, using a HOA-based through-focus an

94 mples from 20 ovarian cancer patients and 10 age-matched controls-of exosome subpopulations expressin

95 Mice on a control diet served as age-matched controls.

96 od in type 2 diabetic (T2DM) subjects versus age-matched controls.

97 infections and allergic disease compared to age-matched controls.

98 currently treated with a statin compared to age-matched controls.

99 er was slower in pDGS patients compared with age-matched controls.

100 e of other neurodegenerative disorders or of age-matched controls.

101 fter the initial dose with de novo-immunized age-matched controls.

102 ren in the CHAPAS-3 Trial and HIV-uninfected age-matched controls.

103 ved increased excitatory input compared with age-matched controls.

104 and recurrent anterior uveitis compared with age-matched controls.

105 somes from post-mortem AD brains compared to age-matched controls.

106 ions from 42 multiple sclerosis cases and 12 age-matched controls.

107 olar Type II/III shoulder instability and 16 age-matched controls.

108 ol study of men with non-obstructive HCM and age-matched controls.

109 tinel node biopsy (Group 2) and nine healthy age-matched controls.

110 ith severe chronic hemiparetic stroke and 12 age-matched controls.

111 showed normal spatial memory as compared to age-matched controls.

112 testis weight that is around 10% lower than age-matched controls.

113 atients post mortem was observed compared to age-matched controls.

114 ic regions of rats with tinnitus compared to age-matched controls.

115 (after 7 months of high-fat diet [HFD]) and age-matched controls.

116 erican football players, but not in sex- and age-matched controls.

117 prised patients with Alzheimer's disease and age-matched controls.

118 9 with visual hallucinations) and 34 healthy age-matched controls.

119 ter complete spinal transection, compared to age-matched controls.

120 ngle matching in 12 HSAN III patients and 12 age-matched controls.

121 ng transplant patients (n = 11), and healthy aged-matched controls (n = 10).

122 ng transplant patients (n = 18), and healthy aged-matched controls (n = 10).

123 GF2, and IGFBP1-7 levels were measured in an age-matched, cross-sectional cohort at varying stages of

124 lex cultures upon transcriptomic analysis of age-matched cultures.

125 r remission prediction in three independent, age-matched data sets, respectively.

126 Transcriptome analyses of age-matched deletion mice show that RBMXL2 controls spli

127 c resonance were identified and grouped into age-matched +DMDAC and -DMDAC.

128 Thirty +DMDAC and 30 age-matched -DMDAC patients were included with a total o

129 ndrome Clinical Trials [IMPAACT] P1060); 183 age-matched, exposed but uninfected (HEU) children; and

130 eyes (226 eyes of former EP infants and 128 age-matched full-term control eyes) from 177 young adult

131 - and post-GBCA exposure comparisons) and 57 age-matched GBCA-naive control subjects.

132 set type 1/type 2 diabetes (n = 206/381) and age-matched glucose-tolerant control subjects (control 1

133 /- 9 [standard deviation]; 58 women) and 100 age-matched HC participants (mean age, 73 years +/- 9; 6

134 with AD recruited between 2010 and 2016 and age-matched HC participants selected from 2010 to 2014 w

135 ain tumor survivors [11.81 +/- 3.27)] and 24 age matched healthy children [12.04 +/- 3.28)] in functi

136 and 70 decreased proteins in DMD relative to age matched healthy controls (p value < 0.05 after adjus

137 21 plasma samples and 27 fecal samples from age-matched healthy children living in the same area.

138 ommon among malnourished children than among age-matched healthy children.

139 deviation, 44 years +/- 15; 45 women) and 28 age-matched healthy control participants (mean age, 44 y

140 seropositive participants with NMOSDs and in age-matched healthy control participants acquired betwee

141 ty-nine highly myopic patients (46 eyes), 11 age-matched healthy control subjects (21 eyes), and 34 p

142 +/- 16 [standard deviation]; 10 men) and 11 age-matched healthy control subjects (54 years +/- 15; e

143 ; and Netherton syndrome, n = 4), as well as age-matched healthy control subjects (n = 14), patients

144 ssive multiple sclerosis participants and 11 age-matched healthy control subjects to undergo 7 T imag

145 .66 +/- 2.53 mmol/mol [9.1 +/- 1.8%]) and 48 age-matched healthy control subjects underwent CCM.

146 patients with acute ischaemic stroke and 17 age-matched healthy control subjects.

147 osine, and histidine levels compared with 10 age-matched healthy control subjects.

148 with genetically proven Fabry disease and 19 age-matched healthy control subjects.

149 in cementum density ( P = 0.009) compared to age-matched healthy control teeth.

150 In this study, seventeen patients and age-matched healthy controls (HC) performed a variant of

151 ot (non-converters, NCON) and we compared to age-matched healthy controls (HC).

152 SPOT) in recent-onset psychosis patients and age-matched healthy controls (HC).

153 iduals [27 freezers, 22 non-freezers, and 21 age-matched healthy controls (HC)] performed a 'GO'-comm

154 children with AD, ADHD, comorbid AD/ADHD and age-matched healthy controls and to investigate aspects

155 s of the illness and used samples from seven age-matched healthy controls for comparisons.

156 duals with sporadic Parkinson's disease, and age-matched healthy controls seen from November, 2012, t

157 2DM (glycated hemoglobin, 6.9+/-1.0%) and 12 age-matched healthy controls underwent assessment of car

158 rns with complex CHD prior to surgery and 30 age-matched healthy controls using brain MRI.

159 ies that were induced to express Abeta42 and age-matched healthy controls using label-free quantitati

160 0.05) in women suffering rUTIs, compared to age-matched healthy controls with concentrations further

161 vere asthma, 8 with mild/moderate asthma, 16 age-matched healthy controls) aged 6 to 17 years old wer

162 p-tau-derived peptides between PD patients, age-matched healthy controls, and young healthy controls

163 T) scans in 19 schizophrenia patients and 20 age-matched healthy controls, here we show a significant

164 In this study of patients with ESKD and age-matched healthy controls, we used arterial spin labe

165 with secondary progressive MS, along with 10 age-matched healthy controls, were prospectively recruit

166 t mass, and worse quality of life (QoL) than age-matched healthy controls.

167 rneal ulcer, treated with topical rhNGF, and age-matched healthy controls.

168 udy enrolled 17 LDH patients and 17 sex- and age-matched healthy individuals.

169 a very first longitudinal study, compared to age-matched healthy male controls, with the purpose of i

170 uire 6-mm macular scans from RP patients and age-matched healthy participants at a tertiary academic

171 urons, astrocytes, and microglia relative to age-matched healthy subject controls.

172 helial cells in type 2 diabetic patients and age-matched healthy subjects by specular microscopy.

173 lifetimes in the parafoveal region, whereas age-matched healthy subjects did not.

174 ents with GA due to AMD, CNV due to AMD, and age-matched healthy subjects presenting to the Doheny-UC

175 o long-lasting hyperpolarization compared to age-matched healthy subjects, indicating greater inward

176 e-surgical TLE patients (7 MRI-negative) and age-matched healthy volunteers were scanned at 7T.

177 ) concentrations in 64 women with IBS and 32 age-matched healthy women (HCs) and investigated their a

178 and nadir platelet counts <30 x 109/L and 18 aged-matched healthy controls, we used susceptibility-we

179 dopamine replacement therapy, along with 50 age-matched, healthy control subjects using resting stat

180 dying with CHB and three healthy gestational age-matched hearts, and 3) autopsy tissue from three add

181 previous report on LSC proteomes to healthy age-matched hematopoietic stem and progenitor cells (HSP

182 ty was more common among older HIV+ MSM than age-matched HIV- MSM controls and was associated with hi

183 ART-treated HIV-infected adults relative to age-matched HIV-negative adults (P = .01, P = .01, and P

184 ntiretroviral therapy (ART) and 60 frequency age-matched HIV-uninfected children aged 4-9 years in Jo

185 of 314,017 HPV-vaccinated girls and 314,017 age-matched HPV-unvaccinated girls (cohort analyses); 11

186 requently mutated in ATL than did high-risk, age-matched HTLV-1 carriers who remained ATL-free after

187 rformed a comparative study on AD, NDAN, and aged-matched human postmortem frontal cortices of either

188 -/-) double knockout mice were compared with age-matched hyperglycemic ApoE(-/-) littermates.

189 They were compared with age-matched IM controls.

190 r cortical atrophy, referenced to 15 healthy age-matched individuals and 21 patients with typical Alz

191 Future studies with higher numbers of age-matched individuals are needed to definitively under

192 with wet AMD, patients with dry AMD, and in age-matched individuals without AMD as controls.

193 poral dementia syndromes relative to healthy age-matched individuals.

194 d compared findings to stool samples from 16 age-matched infants in the United States (US).

195 VLs were higher in outpatients than in age-matched inpatients.

196 was 7.6- or 13.5-fold greater than those in age-matched KI mice.

197 et-induced obese (DIO) mice as compared with age-matched lean controls.

198 In male mice, compared with their age-matched littermate WT controls, Keap1 Ht mice showed

199 atial reference memory compared with APP/PS1 aged-matched littermates.

200 ared with 4.6 +/- 1.4 mL/cm(3) of a sex- and age-matched MAB.

201 XDP patients carrying a TAF1 mutation and 19 age-matched male controls.

202 Age-matched male Fischer 344 rats underwent a 30-minute

203 ne responses to vaccines and infections than age-matched males, but also suffer greater immunopatholo

204 dence in premenopausal females compared with age-matched males.

205 ausal women have lower incidence of T2D than age-matched men and suggest that targeting ERalpha can b

206 greater in premenopausal women compared with age-matched men, and metabolism-related cardiovascular d

207 old had a mortality rate similar to that of age-matched men, but considerably higher than that predi

208 dence of type 2 diabetes (T2D) compared with age-matched men, but this advantage disappears after men

209 entrations are higher in serum from HGPS vs. age-matched mice.

210 This attrition was absent in age-matched mutation carriers who did not have MDS/AML.

211 n myofiber cross-sectional areas compared to age-matched naive controls.

212 subsequent bacterial challenge, relative to age-matched naive mice.

213 linguistic experience, rather than those in age-matched native-signing children, who have similar bi

214 Age-matched nBmp2NLS(tm) and wild type mice were analyze

215 om ASD children, their non-ASD siblings, and age-matched neurotypical children aged 3 to 16 years of

216 human temporal lobe between AD patients and age-matched non-AD controls.

217 1) and wet AMD (P < .05) were higher than in age-matched non-AMD controls, while there was no differe

218 lin 1 (PSEN1) E280A (Glu280Ala) mutation and age-matched non-carriers from the Colombian autosomal do

219 Herein, streptozotocin-induced T1DM rats and age-matched non-diabetic rats were subjected to daily un

220 y, as well as shorter time to viremia versus age-matched non-IPF control subjects (P < 0.001).

221 We studied IPF-LTRs (n = 42) and age-matched non-IPF-LTRs (n = 42) and assessed CMV outco

222 Samples from age-matched non-neuropathic individuals were used as con

223 severe disease in pregnant women compared to age-matched non-pregnant women.

224 gnificantly different from sham-operated and age-matched non-surgical mice at the time of high-fat di

225 of 12-months-old APP(E693Q) as compared with age-matched non-transgenic littermates, and western blot

226 hs after treatment with chemotherapy than do age-matched noncancer controls.

227 tobacco smokers (12 females) and 25 sex- and age-matched nonsmokers) participated in two same-day [(1

228 in high in myopic subjects compared with an age-matched normal control group using ultra widefield o

229 iocapillaris in myopic eyes compared with an age-matched normal control group.

230 rejection, 23 eyes without rejection) and 9 age-matched normal controls.

231 Compared with age-matched normal human CD cells, CD-derived renal cyst

232 One eye each of 39 glaucoma and 31 age-matched normal participants was scanned using 4.5-mm

233 f 45 perimetric glaucoma participants and 37 age-matched normal participants were scanned using 4.5-m

234 te hydatidiform mole (HM) and 20 gestational-age-matched normal pregnant women (control).

235 time-on-task effect on the 10 min PVT as the age-matched normal sleepers group, with similar findings

236 ndividuals with sleep-onset insomnia and the age-matched normal sleepers, lapses of attention and fal

237 on and reduced temporal acuity compared with age-matched normal-hearing (NH) controls.

238 in both older hearing-impaired listeners and age-matched normal-hearing controls.

239 gn hepatobiliary disorders (BHD) and 20 from age-matched "normal controls"(NC).

240 (AREDS grade 1-4 on simplified scale) and 34 age-matched normals (AREDS grade 0).

241 ctivity in human glaucomatous AH compared to age-matched normotensive control AH.

242 eously hypertensive (SHR) rats compared with age-matched normotensive Wistar-Kyoto rats (WKY).

243 ns before and after learning to drum, and 16 age matched novice control participants.

244 We studied male and female mice in age-matched or body weight-matched conditions.

245 pendent set of PD and control donors (either age-matched or young controls).

246 ued regular care (standard care; n = 13); no age-matched pairing was performed.

247 There were 634 age-matched pairs for a total sample of 1,268 MSM of 1,7

248 isuomotor rotations, performing similarly to age-matched participants (older controls).

249 impairment, 9912 survey controls, and 22 873 age-matched participants from the general population, an

250 a (mean illness duration = 17 years), and 88 age-matched participants without major psychiatric illne

251 s with HB at three treatment stages, 30 from age-matched patients with benign hepatobiliary disorders

252 egardless of whether the other person was an age-matched peer or an adult.

253 in the patients were not different from the age-matched posttreatment controls.

254 els are significantly reduced in gestational age-matched preeclamptic vs. normal placentas, whereas L

255 isotropy (FA) values in patients than in the age-matched pretreatment controls (p = 0.017; median dif

256 anges with hyperplasia in prostates, whereas age-matched Pten littermates developed high-grade prosta

257 ible infections (TTIs) among 583 MSM and 583 age-matched repeat male blood donors.

258 We also enrolled an age-matched sample from the general population.

259 mni athletes (N=33, aged 34-71 years) and an age-matched sample of comparison participants (N=18) wer

260 REM2-deficient (Trem2-/-) mice compared with age-matched, sex-matched, and genetic background-matched

261 TIs at three Dutch teaching hospitals and in age-matched, sex-matched, and time-matched healthy child

262 ns were resistant to excitability changes in age-matched SOD1(G93A) mice.

263 ding non-ST elevation MI, along with healthy age-matched subjects, were collected to assess chemokine

264 In an age-matched subsample of INTERVAL, effect sizes for the

265 somes from nonsymptomatic mice with those in age-matched symptomatic mice.

266 glucose and insulin tolerance compared with age-matched T1D rats.

267 s (a) greater in young ASD cases compared to age-matched TD controls (<18 years old) and (b) decrease

268 recruited via public advertisement) who were age matched to the A53T SNCA carriers.

269 oteins (MBGs) in 65 children with ASD and 65 age-matched typically developing (TD) children were comp

270 copy ((1)H-MRS) in 28 adults with ASD and 29 age-matched typically developing (TD) individuals.

271 om 516 children with ASD with those from 164 age-matched typically developing children recruited into

272 of SOR and 21 with low levels of SOR) and 27 age-matched typically developing youths (ages 8-17).

273 ondary to influenza A(H1N1) infection and 10 age-matched, uninfected control lungs.

274 reased with age and were higher than seen in age-matched US infants (p < 0.001).

275 or LT with FKBP1b substantially outperformed age-matched vector controls and performed similarly to e

276 .4 years) with choroidal nevi and 14 healthy age-matched volunteers (24 eyes).

277 Study 3 to 4: 10 HFrEF patients and 10 age-matched volunteers were randomized in a crossover de

278 subjects with diabetes but no DME, and from age-matched volunteers without diabetes.

279 CO did not differ between HFrEF patents and age-matched volunteers.

280 response differed between HFrEF patients and age-matched volunteers.

281 OHB were observed in both HFrEF patients and age-matched volunteers.

282 16, and Cd83) in Foxn1(nu/+) (nu/+) mice and age-matched wild-type (+/+) littermate controls.

283 eriod were assessed and compared to those in age-matched wild-type (WT) controls.

284 less apoptotic beta-cells compared with the age-matched wild-type (WT) controls.

285 mice when compared with MDSPCs isolated from age-matched wild-type (WT) mice.

286 rom male and female late-stage R6/2 mice and age-matched wild-type controls.

287 ctable by endplate recordings, compared with age-matched wild-type littermates.

288 mice is 1.80-fold higher than that from the age-matched wild-type mice.

289 iron levels in the brain by 32% compared to age-matched wild-type mice.

290 ged M(1) receptor-deficient mice compared to age-matched wild-type mice.

291 isometric force in limb muscles compared to age-matched wild-type mice.

292 ry children's hospital; 51/65 cases could be age matched with controls (children who underwent liver

293 and became significantly higher compared to age-matched WT controls at 12 months.

294 Compared to age-matched WT controls, 12 weeks-old SOD1-G93A mice exh

295 HGPS model resemble changes observed in the age-matched WT controls, including early loss of glycosa

296 in male heterozygous Q175 mice, compared to age-matched WT males.

297 cTnI-G203S or age-matched wt mice were treated with active or inactive

298 9 youth with autism spectrum disorder and 23 age-matched youth with typical development (ages 7-17 ye

299 to be at increased risk of ED compared with age-matched youth without HIV.

300 rial tonometry, we compared ED in YLPHIV and age-matched youth without HIV.